Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.91B P/E - EPS this Y -28.30% Ern Qtrly Grth 8.20%
Income -20.76M Forward P/E 27.13 EPS next Y 16.10% 50D Avg Chg -8.00%
Sales 1.08B PEG 2.57 EPS past 5Y -17.81% 200D Avg Chg 7.00%
Dividend N/A Price/Book 2.50 EPS next 5Y 12.00% 52W High Chg -43.00%
Recommedations 2.40 Quick Ratio 1.99 Shares Outstanding 45.99M 52W Low Chg 40.00%
Insider Own 1.57% ROA -0.99% Shares Float 42.60M Beta 0.83
Inst Own 103.20% ROE -1.76% Shares Shorted/Prior 2.28M/1.98M Price 64.58
Gross Margin 41.63% Profit Margin -1.92% Avg. Volume 426,117 Target Price 44.50
Oper. Margin 1.17% Earnings Date Oct 31 Volume 1,388,781 Change 4.67%
About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Omnicell, Inc. News
12/24/24 Here's Why You Should Add HAE Stock to Your Portfolio Now
12/20/24 The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories
12/19/24 4 Healthcare Technology Innovators to Invest in Before the New Year
12/18/24 Why Omnicell (OMCL) Might be Well Poised for a Surge
12/12/24 What Makes Omnicell (OMCL) a New Strong Buy Stock
12/12/24 Omnicell Introduces OmniSphere Platform, Stock to Gain
12/09/24 Omnicell Announces OmniSphere
12/05/24 The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health
12/04/24 5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025
11/29/24 Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report?
11/29/24 Should You Investigate Omnicell, Inc. (NASDAQ:OMCL) At US$48.46?
11/22/24 Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
11/21/24 Wall Street Analysts Believe Omnicell (OMCL) Could Rally 26.73%: Here's is How to Trade
11/20/24 Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering
11/18/24 Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes
11/18/24 Here's Why You Should Add OMCL Stock to Your Portfolio Now
11/06/24 Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock
11/02/24 Omnicell Third Quarter 2024 Earnings: EPS Beats Expectations
11/01/24 A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
10/31/24 OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LIPPS RANDALL A CHAIRMAN, PRESIDENT.. CHAIRMAN, PRESIDENT AND CEO Jun 08 Buy 73.76 4,000 295,040 318,768 06/12/23
Seidelmann Scott Peter EVP, CHIEF COMMERCIA.. EVP, CHIEF COMMERCIAL OFFICER Nov 28 Sell 51.46 1,793 92,268 38,996 11/30/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 26 Option 61.58 15,500 954,490 76,826 08/30/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 26 Sell 108.52 15,500 1,682,060 61,326 08/30/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 22 Option 44.25 11,000 486,750 72,326 08/24/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 22 Sell 105.93 11,000 1,165,230 61,326 08/24/22
LIPPS RANDALL A CHAIRMAN, PRESIDENT.. CHAIRMAN, PRESIDENT AND CEO Aug 16 Sell 111.04 13,000 1,443,520 302,049 08/18/22
Seidelmann Scott Peter EVP, CHIEF COMMERCIA.. EVP, CHIEF COMMERCIAL OFFICER Jun 15 Sell 109.86 3,765 413,623 40,789 06/17/22
Seidelmann Scott Peter EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 14 Sell 133.11 2,525 336,103 48,380 03/16/22
PARRISH MARK W Director Director Mar 10 Option 14.87 2,000 29,740 42,558 03/11/22
PARRISH MARK W Director Director Feb 18 Option 14.87 3,000 44,610 40,558 02/22/22
JOHNSTON DAN S EVP & Chief Legal &.. EVP & Chief Legal & Admin Dec 15 Sell 177.06 1,063 188,215 25,831 12/16/21
Seidelmann Scott Peter EVP, Chief Commercia.. EVP, Chief Commercial Officer Dec 15 Sell 177.24 3,628 643,027 33,632 12/16/21
Kuipers Peter J. Executive V P& CFO Executive V P& CFO Dec 08 Option 0 5,640 59,592 12/08/21
Kuipers Peter J. Executive V P& CFO Executive V P& CFO Dec 08 Sell 181.15 8,517 1,542,855 51,075 12/08/21
SPEARS JOSEPH BRIAN Chief Accounting Off.. Chief Accounting Officer & VP Dec 07 Sell 180.98 8,155 1,475,892 9,399 12/08/21
JOHNSTON DAN S EVP & Chief Legal &.. EVP & Chief Legal & Admin Oct 26 Option 0 10,451 39,427 10/27/21
JOHNSTON DAN S EVP & Chief Legal &.. EVP & Chief Legal & Admin Oct 26 Sell 170 10,451 1,776,670 28,976 10/27/21
Kuipers Peter J. Executive V P& CFO Executive V P& CFO May 18 Sell 135.59 2,395 324,738 69,454 05/18/21
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 09 Option 0 25,000 177,116 12/09/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 09 Sell 122.61 25,000 3,065,250 152,116 12/09/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 08 Option 0 17,500 152,767 12/08/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 08 Sell 110.8 17,500 1,939,000 152,116 12/08/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Nov 23 Option 0 15,000 164,716 11/23/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Nov 23 Sell 105.21 15,000 1,578,150 152,116 11/23/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Nov 04 Sell 89.83 11,435 1,027,206 229,113 11/04/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Sep 16 Sell 75.59 15,143 1,144,659 240,548 09/16/20